TRACON Announces FDA Orphan Drug Designation for TRC105 in Soft Tissue Sarcoma
Jan 25, 2016 13:00 pm UTC| Business
SAN DIEGO, Jan. 25, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
FXCM Integrates CFD Pricing Into FlexTrade’s Technology
Jan 25, 2016 13:00 pm UTC| Business
NEW YORK, Jan. 25, 2016 -- FXCM Inc.(NYSE:FXCM) ("FXCM" or "the Company"), a leading online provider of foreign exchange (FX) trading and related services, with FlexTrade Systems Inc., a global leader in high...
Vascular Solutions Launches New VSI Radial™ Introducer Sheaths
Jan 25, 2016 13:00 pm UTC| Business
-Enhanced radial introducer sheaths feature superior sheath-to-dilator transition and extended hydrophilic coating for smooth radial access -17 models and three kit configurations designed to meet the needs of a variety of...
Jan 25, 2016 12:45 pm UTC| Business
VALLEY COTTAGE, N.Y., Jan. 25, 2016 -- According to the latest market report published by Future Market Insights, titled “Ophthalmic Diagnostic Equipment Market: Global Industry Analysis and Opportunity Assessment...
Jan 25, 2016 12:31 pm UTC| Business
Preliminary analysis of baseline MET incidence in METIV-HCC trial confirms results observed in phase 2 trial BURLINGTON, Mass., Jan. 25, 2016 -- ArQule, Inc. (NASDAQ:ARQL) today announced that an analysis of...
Jan 25, 2016 12:31 pm UTC| Business
Preliminary analysis of baseline MET incidence in METIV-HCC trial confirms results observed in phase 2 trial BURLINGTON, Mass., Jan. 25, 2016 -- ArQule, Inc. (NASDAQ:ARQL) today announced that an analysis of...
OncoMed Provides Update on Tarextumab Phase 2 Pancreatic Cancer ALPINE Trial
Jan 25, 2016 12:30 pm UTC| Business
REDWOOD CITY, Calif., Jan. 25, 2016 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, announced an update on the Phase 2...